Severe/Moderate Coronavirus

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Severe/Moderate Coronavirus trials may be worth asking about

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06490744

Evolution of Respiratory Function in Lung Transplant Patients With Moderate to Severe Covid-19 Infection

The SARS-Cov-2 infection pandemic has caused a large number of acute respiratory failures and deaths across the world. Certain factors have been identified as a…

France75 participantsStarted 2023-09-04Updated 2024-07-08

All recent trials (100 shown)

Active — Not RecruitingPhase 1/2

NCT04565665

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

This is a phase I trial followed by a phase II randomized trial. The purpose of phase I study is the feasibility of treating patients with acute respiratory dis…

United States65 participantsStarted 2020-07-29Updated 2026-05-20

Treatment: Best Practice, Mesenchymal Stem Cell

TerminatedPhase 3

NCT04516811

Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19

A prospective, randomized, placebo-controlled, double-blinded, phase III clinical trial of the therapeutic use of convalescent plasma in the treatment of patien…

South Africa102 participantsStarted 2020-09-21

Severe/Moderate Coronavirus

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Evolution of Respiratory Function in Lung Transplant Patients With Moderate to Severe Covid-19 Infection

All recent trials (100 shown)

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Evolution of Respiratory Function in Lung Transplant Patients With Moderate to Severe Covid-19 Infection

All recent trials (100 shown)

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19

A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.

Calprotectin, a Biomarker of COVID-19 Severity (CALPRO)

A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High…

Study of LAU-7b for the Treatment of Long COVID in Adults

Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS

Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia

A Study to Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19

A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-1…

Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients

Treat COVID-19 Patients With Regadenoson

Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

Transcranial Non-invasive Electrical Stimulation of the Vagus Nerve in Hospitalized Moderate-to-severe COVID-19 Patients

Tafenoquine in Patients With Mild to Moderate COVID-19

Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-…

An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving t…

Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe Illness

A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease